IOL CHEMICALS & PHARM. | ZANDU REALTY | IOL CHEMICALS & PHARM./ ZANDU REALTY |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.1 | 24.2 | 54.1% | View Chart |
P/BV | x | 1.5 | 0.8 | 192.7% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. ZANDU REALTY |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
ZANDU REALTY Mar-17 |
IOL CHEMICALS & PHARM./ ZANDU REALTY |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 1,670 | 32.1% | |
Low | Rs | 272 | 1,030 | 26.4% | |
Sales per share (Unadj.) | Rs | 377.6 | 63.3 | 596.6% | |
Earnings per share (Unadj.) | Rs | 23.7 | 63.9 | 37.1% | |
Cash flow per share (Unadj.) | Rs | 31.6 | 63.9 | 49.4% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 2,438.1 | 10.5% | |
Shares outstanding (eoy) | m | 58.71 | 0.81 | 7,248.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 21.2 | 5.0% | |
Avg P/E ratio | x | 17.1 | 21.0 | 81.2% | |
P/CF ratio (eoy) | x | 12.8 | 21.0 | 60.9% | |
Price / Book Value ratio | x | 1.6 | 0.6 | 285.7% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 1,089 | 2,180.9% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 3 | 54,970.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 51 | 43,243.8% | |
Other income | Rs m | 256 | 117 | 219.2% | |
Total revenues | Rs m | 22,427 | 168 | 13,342.4% | |
Gross profit | Rs m | 2,257 | -37 | -6,061.5% | |
Depreciation | Rs m | 462 | 0 | - | |
Interest | Rs m | 165 | 14 | 1,156.6% | |
Profit before tax | Rs m | 1,887 | 65 | 2,886.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | 14 | 3,645.8% | |
Profit after tax | Rs m | 1,391 | 52 | 2,687.1% | |
Gross profit margin | % | 10.2 | -72.6 | -14.0% | |
Effective tax rate | % | 26.2 | 20.8 | 126.3% | |
Net profit margin | % | 6.3 | 101.0 | 6.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 270 | 3,585.6% | |
Current liabilities | Rs m | 5,025 | 118 | 4,262.6% | |
Net working cap to sales | % | 20.9 | 295.9 | 7.1% | |
Current ratio | x | 1.9 | 2.3 | 84.1% | |
Inventory Days | Days | 43 | 12,983 | 0.3% | |
Debtors Days | Days | 8 | 0 | - | |
Net fixed assets | Rs m | 11,017 | 1,824 | 604.1% | |
Share capital | Rs m | 587 | 81 | 728.1% | |
"Free" reserves | Rs m | 14,490 | 1,894 | 765.0% | |
Net worth | Rs m | 15,077 | 1,975 | 763.5% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 2,093 | 988.1% | |
Interest coverage | x | 12.5 | 5.6 | 222.8% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0 | 4,376.4% | |
Return on assets | % | 7.5 | 3.2 | 238.6% | |
Return on equity | % | 9.2 | 2.6 | 352.0% | |
Return on capital | % | 13.6 | 4.0 | 337.6% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | 59 | 2,055.3% | |
From Investments | Rs m | -1,200 | -160 | 751.0% | |
From Financial Activity | Rs m | -41 | 101 | -40.9% | |
Net Cashflow | Rs m | -18 | 0 | -6,571.4% |
Indian Promoters | % | 48.2 | 35.5 | 135.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 0.1 | 1,307.7% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 64.5 | 80.3% | |
Shareholders | 130,003 | 22,589 | 575.5% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | Zandu Realty | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -1.58% | 2.63% | -0.80% |
1-Month | -4.89% | -6.21% | 1.79% |
1-Year | -4.48% | 48.78% | 49.29% |
3-Year CAGR | -12.13% | 7.79% | 14.07% |
5-Year CAGR | 15.26% | 12.55% | 19.11% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the Zandu Realty share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of Zandu Realty the stake stands at 35.5%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of Zandu Realty.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
Zandu Realty paid Rs 0.0, and its dividend payout ratio stood at 0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of Zandu Realty.
For a sector overview, read our pharmaceuticals sector report.
Asian markets traded lower on Friday tracking overnight losses on Wall Street and inflation data from Japan.